Oct 03, 2011, 05.43 PM IST | Source: CNBC-TV18

FCCB case: Bombay HC adjourns Wockhardt hearing to Oct 11

Pharma major Wockhardt now has additional time on its hands to finalise a formal repayment plan for its overseas bond holders.

After the Bell

Excerpts from After the Bell on CNBC-TV18 Watch the full show »

Pharma major Wockhardt now has additional time on its hands to finalise a formal repayment plan for its overseas bond holders.

The company has total dues of Rs 358 crore it was supposed to revert to the Bombay High Court with a detailed plan by October 3.

It now has extra time as the court today adjourned the case to October 11.

A group of bondholders led by the bond trustee of the Bank of New York Mellon, Sun Pharma Global and hedge fund QVT besides some creditors had taken Wockhardt to court, filing a wind-up petition, after the company defaulted on repayment of its USD 110-million FCCBs, in 2009.

Wockhardt stock price

On April 16, 2014, Wockhardt closed at Rs 617.60, down Rs 13.55, or 2.15 percent. The 52-week high of the share was Rs 1944.85 and the 52-week low was Rs 336.60.


The company's trailing 12-month (TTM) EPS was at Rs 29.97 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 20.61. The latest book value of the company is Rs 74.55 per share. At current value, the price-to-book value of the company is 8.28.

Set email alert for

ADS BY GOOGLE

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Narendra Modi

82013.35 2,004.74 2.51%

7491

Bought today

3852

Sold today

2.08%

User holding

video of the day

Ambit Cap eyes two years of market cheer; bets on cyclicals

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.